JPMORGAN CHASE & CO - RAPTOR PHARMACEUTICAL CORP ownership

RAPTOR PHARMACEUTICAL CORP's ticker is RPTP and the CUSIP is 75382F106. A total of 71 filers reported holding RAPTOR PHARMACEUTICAL CORP in Q3 2013. The put-call ratio across all filers is 42.12 and the average weighting 0.1%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of RAPTOR PHARMACEUTICAL CORP
ValueSharesWeighting
Q3 2016$4,661,000
+93.2%
519,632
+15.6%
0.00%0.0%
Q2 2016$2,413,000
+64.3%
449,409
+40.7%
0.00%
Q1 2016$1,469,000
-18.1%
319,435
-7.4%
0.00%
Q4 2015$1,794,000
+506.1%
344,900
+1415.0%
0.00%
Q4 2013$296,000
-97.3%
22,765
-96.9%
0.00%
-100.0%
Q3 2013$10,799,000
+51.4%
723,759
-5.1%
0.00%
+50.0%
Q2 2013$7,134,000762,9780.00%
Other shareholders
RAPTOR PHARMACEUTICAL CORP shareholders Q3 2013
NameSharesValueWeighting ↓
Trellus Management Company, LLC 63,500$1,003,0001.13%
Broadfin Capital, LLC 1,319,883$20,841,0001.12%
BAILARD, INC. 160,000$2,526,0000.39%
Birchview Capital, LP 46,000$726,0000.38%
HIGHLAND CAPITAL MANAGEMENT LP 1,182,167$18,666,0000.38%
Rock Springs Capital Management LP 305,000$4,816,0000.35%
SPHERA FUNDS MANAGEMENT LTD. 206,500$3,261,0000.32%
GLOBEFLEX CAPITAL L P 109,771$1,733,0000.32%
GROUP ONE TRADING, L.P. 1,319,766$20,839,0000.29%
Perceptive Advisors 264,204$4,172,0000.25%
View complete list of RAPTOR PHARMACEUTICAL CORP shareholders